Dopamine Signaling in the Nucleus Accumbens of Animals Self-Administering Drugs of Abuse
Open accessThe DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
Abstract
Abuse of psychoactive substances can lead to drug addiction. In animals, addiction is best modeled by drug self-administration paradigms. It has been proposed that the crucial common denominator for the development of drug addiction is the ability of drugs of abuse to increase extracellular concentrations of dopamine in the nucleus accumbens (NAcc). Studies using in vivo microdialysis and chronoamperometry in the behaving animal have demonstrated that drugs of abuse increase tonic dopamine concentrations in the NAcc. However, it is known that dopamine neurons respond to reward-related stimuli on a subsecond timescale. Thus, it is necessary to collect neurochemical information with this level of temporal resolution, as achieved with in vivo fast-scan cyclic voltammetry (FSCV), to fully understand the role of phasic dopamine release in normal behavior and drug addiction. We review studies that investigated the effects of drugs of abuse on NAcc dopamine levels in freely moving animals using in vivo microdialysis, chronoamperometry, and FSCV. After a brief introduction of dopamine signal transduction and anatomy and a section on current theories on the role of dopamine in natural goal-directed behavior, a discussion of techniques for the in vivo assessment of extracellular dopamine in behaving animals is presented. Then, we review studies using these techniques to investigate changes in phasic and tonic dopamine signaling in the NAcc during (1) response-dependent and -independent administration of abused drugs, (2) the presentation of drug-conditioned stimuli and operant behavior in self-administration paradigms, (3) drug withdrawal, and (4) cue-induced reinstatement of drug seeking. These results are then integrated with current ideas on the role of dopamine in addiction with an emphasis on a model illustrating phasic and tonic NAcc dopamine signaling during different stages of drug addiction. This model predicts that phasic dopamine release in response to drug-related stimuli will be enhanced over stimuli associated with natural reinforcers, which may result in aberrant goal-directed behaviors contributing to drug addiction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Over time, salient drug-related cues release dopamine in the NAc even in the absence of drug taking (Ito et al., 2002, Willuhn et al., 2010).”
From Sensitive periods of substance abuse: Early risk for the transition to dependence (2017) · cites this paper as Willuhn et al., 2010
In the citing paper
“Studies using an in vivo microdialysis technique, which measures minute changes in brain neurotransmitter levels in the behaving animal, have shown that drugs of abuse can increase tonic DA concentrations in the NAc.”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [122]
In the citing paper
“For example, using rodent models, researchers have determined that nearly all psychoactive drugs of abuse (for example, cocaine, amphetamines, alcohol, opiates, cannabinoids, nicotine) induce alterations in the transmission of DA within the mesolimbic pathway, with most of these drugs increasing extracellular concentrations of DA [122].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [122]
In the citing paper
“Drug self-administration is the ‘gold standard’ of animal models of drug abuse [122,129].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [122]
In the citing paper
“From mechanistic neurobiological and behavioral studies in rodents, it has become clear that the mesolimbic pathway is a key component for the rewarding effect of drugs of abuse, and is essential for behaviors related to drug reward, salience, and motivation [122].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [122]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131 · cited 1×
“…dopamine cell groups innervate different functional domains of the striatum; i.e., sensorimotor, associative, and limbic circuits that are mainly defined by their differential cortical inputs (Carlsson et al. 1962; Dahlstrom and Fuxe 1964; Alexander and Crutcher 1990; Joel and Weiner 2000).”
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“Dopamine is thought to facilitate reinforcement learning by “stamping in” stimulus-reward associations (Wise 2004), providing a prediction error (Montague et al.”
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
The debate over dopamine’s role in reward: the case for incentive salience
Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331 · cited 3×
“…the NAcc caused an increase in locomotion that can be inhibited by blocking the effect of NAcc output in one of its motor output nuclei (Jones and Mogenson 1980), supporting the proposition that NAcc dopamine serves as a modulator in the translation of motivation into action (Mogenson et al. 1980).”
Influential
Cited by
Addiction circuitry in the human brain
Volkow, N. D., Wang, G.-J., Fowler, J. S., & Tomasi, D. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134625 · Cited by 592
Sex differences, gender and addiction
Becker, J. B., McClellan, M. L., & Reed, B. G. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.23963 · Cited by 557
Sensitive periods of substance abuse: Early risk for the transition to dependence
Jordan, C. J., & Andersen, S. L. (2017) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2016.10.004 · Cited by 455
Baumann, M. H., Ayestas, M. A., Partilla, J. S., Sink, J. R., Shulgin, A. T., Daley, P. F., Brandt, S. D., Rothman, R. B., Ruoho, A. E., & Cozzi, N. V. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.304 · Cited by 439
The ins and outs of the striatum: Role in drug addiction
Yager, L. M., Garcia, A. F., Wunsch, A. M., & Ferguson, S. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.033 · Cited by 417
Baumann, M. H., Partilla, J. S., Lehner, K. R., Thorndike, E. B., Hoffman, A. F., Holy, M., Rothman, R. B., Goldberg, S. R., Lupica, C. R., Sitte, H. H., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.204 · Cited by 408
Synaptic mechanisms underlying persistent cocaine craving
Wolf, M. E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.39 · Cited by 393
Exercise as a novel treatment for drug addiction: A neurobiological and stage-dependent hypothesis
Lynch, W. J., Peterson, A. B., Sanchez, V., Abel, J., & Smith, M. A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.011 · Cited by 376
Ashok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0135 · Cited by 330
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
An integrative perspective on the role of dopamine in schizophrenia
Maia, T. V., & Frank, M. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.021 · Cited by 293
Krueger, R. F., Hobbs, K. A., Conway, C. C., Dick, D. M., Dretsch, M. N., Eaton, N. R., Forbes, M. K., Forbush, K. T., Keyes, K. M., Latzman, R. D., et al. (2021) · World Psychiatry · doi:10.1002/wps.20844 · Cited by 262
A Review of Alprazolam Use, Misuse, and Withdrawal
Ait-Daoud, N., Hamby, A. S., Sharma, S., & Blevins, D. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000350 · Cited by 195
Calipari, E. S., Ferris, M. J., Zimmer, B. A., Roberts, D. C., & Jones, S. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.136 · Cited by 178
Adolescent brain development in normality and psychopathology
Luciana, M. (2013) · Development and Psychopathology · doi:10.1017/s0954579413000643 · Cited by 154
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines
Baumann, M. H., Solis, E., Watterson, L. R., Marusich, J. A., Fantegrossi, W. E., & Wiley, J. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3223-14.2014 · Cited by 186
Amphetamine Paradoxically Augments Exocytotic Dopamine Release and Phasic Dopamine Signals
Daberkow, D. P., Brown, H. D., Bunner, K. D., Kraniotis, S. A., Doellman, M. A., Ragozzino, M. E., Garris, P. A., & Roitman, M. F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2136-12.2013 · Cited by 165
Reward processing in anorexia nervosa
Keating, C., Tilbrook, A. J., Rossell, S. L., Enticott, P. G., & Fitzgerald, P. B. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.01.036 · Cited by 172
The Influence of Palatable Diets in Reward System Activation: A Mini Review
de Macedo, I. C., de Freitas, J. S., & da Silva Torres, I. L. (2016) · Advances in Pharmacological Sciences · doi:10.1155/2016/7238679 · Cited by 141
Luciana, M., Wahlstrom, D., Porter, J. N., & Collins, P. F. (2012) · Developmental Psychology · doi:10.1037/a0027432 · Cited by 156
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript to be modulated by tonic DA levels (Ostlund, Wassum, Murphy, Balleine, & Maidment, 2011; Niv, Daw, Joel & Dayan, 2007; Willuhn et al. 2010).”
BackgroundInfluentialβ-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors
Slosky, L. M., Bai, Y., Tóth, K., Ray, C., Rochelle, L. K., Badea, A., Chandrasekhar, R., Pogorelov, V. M., Abraham, D., Atluri, N., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.053 · Cited by 160
Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs
Baumann, M. H., Bukhari, M. O., Lehner, K., Anizan, S., Rice, K. C., Concheiro, M., & Huestis, M. A. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_53 · Cited by 139
Neuropharmacology of Synthetic Cathinones
Baumann, M. H., Walters, H. M., Niello, M., & Sitte, H. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_178 · Cited by 151
Ostlund, S. B., LeBlanc, K. H., Kosheleff, A. R., Wassum, K. M., & Maidment, N. T. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.96 · Cited by 142
Effects of Drugs of Abuse on the Blood-Brain Barrier: A Brief Overview
Pimentel, E., Sivalingam, K., Doke, M., & Samikkannu, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00513 · Cited by 138
Incentive Motivation, Cognitive Control, and the Adolescent Brain: Is It Time for a Paradigm Shift?
Luciana, M., & Collins, P. F. (2012) · Child Development Perspectives · doi:10.1111/j.1750-8606.2012.00252.x · Cited by 123
An updated review on synthetic cathinones
Soares, J., Costa, V. M., Bastos, M. D. L., Carvalho, F. D., & Capela, J. P. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03083-3 · Cited by 133
Gu, H. C., Varner, E. L., Groskreutz, S. R., Michael, A. C., & Weber, S. G. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00633 · Cited by 120
Argument for a non‐linear relationship between severity of human obesity and dopaminergic tone
Horstmann, A., Fenske, W. K., & Hankir, M. K. (2015) · Obesity Reviews · doi:10.1111/obr.12303 · Cited by 106
The neurobiological and behavioral overlaps of nicotine and food addiction
Criscitelli, K., & Avena, N. M. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.08.009 · Cited by 102
Thein vivoneurochemistry of the brain during general anesthesia
Müller, C. P., Pum, M. E., Amato, D., Schüttler, J., Huston, J. P., & Silva, M. A. D. S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07445.x · Cited by 96
Illicit dopamine transients: reconciling actions of abused drugs
Covey, D. P., Roitman, M. F., & Garris, P. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.002 · Cited by 90
Mesolimbic Dopamine Transients in Motivated Behaviors: Focus on Maternal Behavior
Robinson, D. L., Zitzman, D. L., & Williams, S. K. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00023 · Cited by 89
“sex and food, during stress, or following administration of addictive drugs (for review, see Westerink, 1995; Phillips et al., 2008; Willuhn et al., 2010).”
BackgroundAbulseoud, O. A., Miller, J. D., Wu, J., Choi, D.-S., & Holschneider, D. P. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.045 · Cited by 85
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 89
Calipari, E. S., Ferris, M. J., & Jones, S. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12452 · Cited by 76
Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens
Marcott, P. F., Gong, S., Donthamsetti, P., Grinnell, S. G., Nelson, M. N., Newman, A. H., Birnbaumer, L., Martemyanov, K. A., Javitch, J. A., & Ford, C. P. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.038 · Cited by 75
Psychostimulants and brain dysfunction: A review of the relevant neurotoxic effects
Gonçalves, J., Baptista, S., & Silva, A. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.006 · Cited by 85
Taste uncoupled from nutrition fails to sustain the reinforcing properties of food
Beeler, J. A., McCutcheon, J. E., Cao, Z. F. H., Murakami, M., Alexander, E. R., Roitman, M. F., & Zhuang, X. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08167.x · Cited by 87
From controlled to compulsive drug-taking: The role of the habenula in addiction
Mathis, V., & Kenny, P. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.06.018 · Cited by 75
Brain Region-Specific Trafficking of the Dopamine Transporter
Block, E. R., Nuttle, J., Balcita‐Pedicino, J. J., Caltagarone, J., Watkins, S. C., Sesack, S. R., & Sorkin, A. D. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1391-15.2015 · Cited by 78
Bui, E., Nadal-Vicens, M., & M. Simon, N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.2/ebui · Cited by 71
“Activity in the nucleus accumbens, which plays a central role in the reward system, has been shown to be intimately linked to increased dopaminergic activity.(40) Attempts to pharmacologically treat addiction with dopaminergic agents have previously been tried.”
BackgroundCalhoun, S. E., Meunier, C. J., Lee, C. A., McCarty, G. S., & Sombers, L. A. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00351 · Cited by 70
Unidirectional relationship between heroin self-administration and impulsive decision-making in rats
Schippers, M. C., Binnekade, R., Schoffelmeer, A. N. M., Pattij, T., & De Vries, T. J. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2444-8 · Cited by 67
Corbett, C. M., Dunn, E., & Loweth, J. A. (2021) · eNeuro · doi:10.1523/eneuro.0054-21.2021 · Cited by 70
Optogenetic interrogations of the neural circuits underlying addiction
Britt, J. P., & Bonci, A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.010 · Cited by 57
Huang, Y., Ceceli, A. O., Kronberg, G., King, S. G., Malaker, P., Parvaz, M. A., Alia‐Klein, N., Garland, E. L., & Goldstein, R. Z. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20220759 · Cited by 63
Deehan, G. A., Engleman, E. A., Ding, Z., McBride, W. J., & Rodd, Z. A. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12034 · Cited by 61
Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models
Jupp, B., & Dalley, J. W. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12787 · Cited by 65
Neuroimaging of the dopamine/reward system in adolescent drug use
Ernst, M., & Luciana, M. (2015) · CNS Spectrums · doi:10.1017/s1092852915000395 · Cited by 57
Venton, B. J., & DiScenza, D. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821203-5.00004-x · Cited by 58
Aversive motivation and the maintenance of monogamous pair bonding
Resendez, S. L., & Aragona, B. J. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0068 · Cited by 60
Persistent effects of obesity: A neuroplasticity hypothesis
Matikainen‐Ankney, B. A., & Kravitz, A. V. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13665 · Cited by 56
Dawson, P., Opacka‐Juffry, J., Moffatt, J. D., Daniju, Y., Dutta, N., Ramsey, J., & Davidson, C. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.013 · Cited by 59
Cocaine Increases Dopaminergic Neuron and Motor Activity via Midbrain α1 Adrenergic Signaling
Goertz, R. B., Wanat, M. J., Gómez, J. A., Brown, Z. J., Phillips, P. E. M., & Paladini, C. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.296 · Cited by 59
Self-citationHossain, I., Tan, C., Doughty, P. T., Dutta, G., Murray, T. A., Siddiqui, S., Iasemidis, L. D., & Arumugam, P. U. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00500 · Cited by 55
Jiménez‐Urbieta, H., Gago, B., de la Riva, P., Delgado‐Alvarado, M., Marín, C., & Rodríguez-Oroz, M. C. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.010 · Cited by 58
Galaj, E., Ananthan, S., Saliba, M., & Ranaldi, R. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3254-y · Cited by 50
Becker‐Krail, D. D., Walker, W. H., & Nelson, R. J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.886704 · Cited by 52
Namba, M. D., Tomek, S. E., Olive, M. F., Beckmann, J. S., & Gipson, C. D. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00017 · Cited by 54
Local GABAA Receptor-Mediated Suppression of Dopamine Release within the Nucleus Accumbens
Brodnik, Z. D., Batra, A., Oleson, E. B., & España, R. A. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00268 · Cited by 46
Rossi, L. M., Reverte, I., Ragozzino, D., Badiani, A., Vènniro, M., & Caprioli, D. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0479-4 · Cited by 48
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
Urban, M. M., Stingl, M., & Meinhardt, M. W. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1156319 · Cited by 46
Dopamine, vocalization, and astrocytes
Turk, A. Z., Marchoubeh, M. L., Fritsch, I., Maguire, G. A., & SheikhBahaei, S. (2021) · Brain and Language · doi:10.1016/j.bandl.2021.104970 · Cited by 46
Microglia in neuroimmunopharmacology and drug addiction
Li, H., Watkins, L. R., & Wang, X. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02443-6 · Cited by 45
Neuromodulation, Emotional Feelings and Affective Disorders
Pereira, A., & Wang, F. (2015) · Mens Sana monographs · doi:10.4103/0973-1229.154533 · Cited by 52
Cadet, J. L., Brannock, C., Ladenheim, B., McCoy, M. T., Krasnova, I. N., Lehrmann, E., Becker, K. G., & Jayanthi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084665 · Cited by 48
Heilbronner, S. R., & Meck, W. H. (2013) · Behavioural Processes · doi:10.1016/j.beproc.2013.09.013 · Cited by 48
Olanzapine treatment of adolescent rats alters adult reward behaviour and nucleus accumbens function
Vinish, M., Elnabawi, A., Milstein, J. A., Burke, J. S., Kallevang, J. K., Turek, K. C., Lansink, C. S., Merchenthaler, I. J., Bailey, A. M., Kolb, B. E., et al. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001642 · Cited by 42
Wenzel, J. M., Cotten, S. W., Dominguez, H. M., Lane, J. E., Shelton, K., Su, Z.-I., & Ettenberg, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3861-13.2014 · Cited by 38
Schelp, S. A., Brodnik, Z. D., Rakowski, D. R., Pultorak, K. J., Sambells, A. T., España, R. A., & Oleson, E. B. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241802 · Cited by 39
The Role of Mesoaccumbens Dopamine in Nicotine Dependence
Balfour, D. J. K. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_3 · Cited by 40
Sorkina, T., Ma, S., Larsen, M. B., Watkins, S. C., & Sorkin, A. D. (2018) · eLife · doi:10.7554/elife.32293 · Cited by 36
Ramôa, C. P., Doyle, S. E., Lycas, M. D., Chernau, A. K., & Lynch, W. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.09.028 · Cited by 36
Cocaine Use Reverses Striatal Plasticity Produced During Cocaine Seeking
Spencer, S. M., García‐Keller, C., Roberts-Wolfe, D., Heinsbroek, J. A., Mulvaney, M., Sorrell, A., & Kalivas, P. W. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.033 · Cited by 35
Kotlinska, J. H., Bochenski, M., & Danysz, W. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.025 · Cited by 37
Fu, Z., Yang, H., Xiao, Y., Zhao, G., & Huang, H. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-20 · Cited by 38
Moldovan, N., Blaga, I.-I., Billa, S., Hossain, I., Gong, C., Jones, C. E., Murray, T. A., Divan, R., Siddiqui, S., & Arumugam, P. U. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.129795 · Cited by 33
Calipari, E. S., & Jones, S. R. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.021 · Cited by 36
Levy, K. A., Brodnik, Z. D., Shaw, J. K., Perrey, D. A., Zhang, Y., & España, R. A. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4673-y · Cited by 35
Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling
Howard, C. D., Daberkow, D. P., Ramsson, E. S., Keefe, K. A., & Garris, P. A. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12209 · Cited by 34
Adachi, S.-I., Yuki, E. N. D. O., Mizushige, T., Tsuzuki, S., Matsumura, S., Inoue, K., & Fushiki, T. (2013) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.130234 · Cited by 31
Park, T. Y., Nishida, K. S., Wilson, C. M., Jaiswal, S., Scott, J. L., Hoy, A. R., Selwyn, R. G., Dardzinski, B. J., & Choi, K. H. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13542 · Cited by 30
Calcium channels as therapeutic targets
Belardetti, F., & Zamponi, G. W. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.38 · Cited by 29
Motaghinejad, M., Fatima, S., Banifazl, S., Bangash, M. Y., & Karimian, M. (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.188491 · Cited by 29
Traumatic grief research and care in the aftermath of the COVID-19 pandemic
Djelantik, A. A. A. M. J., Bui, É., O’Connor, M., Rosner, R., Robinaugh, D. J., Simon, N. M., & Boelen, P. A. (2021) · European Journal of Psychotraumatology · doi:10.1080/20008198.2021.1957272 · Cited by 30
Astrocytes in Addictive Disorders
Kruyer, A., & Scofield, M. D. (2021) · Advances in neurobiology · doi:10.1007/978-3-030-77375-5_10 · Cited by 27
Dutta, G., Tan, C., Siddiqui, S., & Arumugam, P. U. (2016) · Materials Research Express · doi:10.1088/2053-1591/3/9/094001 · Cited by 26
Binge Drinking's Effects on the Developing Brain-Animal Models.
Hiller-Sturmhöfel, S., & SPEAR, L. P. (2018) · PubMed Central · Cited by 26
Differentiation of Primary Emotions through Neuromodulators: Review of Literature
Gu, S., Wang, F., Yuan, T., Benyu, G., & Huang, J. H. (2015) · International Journal of Neurology Research · doi:10.17554/j.issn.2313-5611.2015.01.19 · Cited by 30
Viscoelasticity of reward and control systems in adolescent risk taking
McIlvain, G., Clements, R. G., Magoon, E. M., Spielberg, J. M., Telzer, E. H., & Johnson, C. L. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116850 · Cited by 30
Holahan, M. R., Madularu, D., McConnell, E. M., Walsh, R., & DeRosa, M. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022239 · Cited by 27
Grinevich, V. P., Zakirov, A. N., Berseneva, U. V., Gerasimova, E., Gainetdinov, R. R., & Budygin, E. A. (2022) · Cells · doi:10.3390/cells11091533 · Cited by 25
Wang, J. M., Zhu, L., Brown, V. M., Garza, R. D. L., Newton, T. F., King‐Casas, B., & Chiu, P. H. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.07.009 · Cited by 24
Duncan, J. R. (2012) · ISRN Neurology · doi:10.5402/2012/972607 · Cited by 26
Acute phenylalanine/tyrosine depletion of phasic dopamine in the rat brain
Shnitko, T. A., Taylor, S. C., Stringfield, S. J., Zandy, S. L., Cofresí, R. U., Doherty, J. M., Lynch, W. B., Boettiger, C. A., Gonzales, R. A., & Robinson, D. L. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4259-0 · Cited by 22
Smith, K. L., Cunningham, J. I., Eyerman, D. J., Dean, R. L., Deaver, D. R., & Sánchez, C. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.015 · Cited by 24
Liu, Y., Montgomery, S. E., Juarez, B., Morel, C., Zhang, S., Kong, Y., Calipari, E. S., Nestler, E. J., Zhang, L., & Han, M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108176 · Cited by 22
Billa, S., Yanamadala, Y., Hossain, I., Siddiqui, S., Moldovan, N., Murray, T. A., & Arumugam, P. U. (2022) · Micromachines · doi:10.3390/mi13071008 · Cited by 20
Advances in studying phasic dopamine signaling in brain reward mechanisms
Addy, N. A. (2013) · Frontiers in Bioscience-Elite · doi:10.2741/e678 · Cited by 25
Metadata
- Authors
- Willuhn, I., Wanat, M. J., Clark, J. J., & Phillips, P. E. M.
- Affiliations
- University of Washington (US)
- Corresponding author
- Willuhn, Ingo
- Venue
- Current Topics in Behavioral Neurosciences
- Publisher
- Springer Berlin Heidelberg
- Published
- 2009-09-15
- Volume
- 3
- Pages
- 29-71
- ISSN
- 1866-3370 (ISSN-L)
- 1866-3389
- PMC
- PMC3766749
- OpenAlex
- W1601443064
- Cited by
- 193
- References
- 281
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 11 · 2021: 16 · 2020: 14 · 2019: 4 · 2018: 19 · 2017: 12 · 2016: 13 · 2015: 14 · 2014: 14 · 2013: 20 · 2012: 20
- FWCI
- 10.80
- Type
- book chapter
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current topics in behavioral neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R21DA021793, R01DA027858)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- dopamine signaling, nucleus accumbens, self-administration, drug addiction, phasic dopamine release, tonic dopamine, fast-scan cyclic voltammetry, in vivo microdialysis, chronoamperometry, drug withdrawal, cue-induced reinstatement, drug-seeking behavior, goal-directed behavior, reward, psychoactive substances
- MeSH terms
- Action Potentials, Animals, Behavior, Animal, Disease Models, Animal, Dopamine, Humans, Motivation, Neurons, Nucleus Accumbens, Reinforcement, Psychology, Self Administration, Signal Transduction, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.